site stats

Jelikalite

Web27 dic 2024 · NEW YORK, NY, USA, December 27, 2024 / EINPresswire.com / -- NEW YORK, December 27, 2024 – JelikaLite is pleased to announce the launch of its StartEngine equity crowdfunding campaign for ... WebFounded Date 2024. Operating Status Active. Last Funding Type Undisclosed. Company Type For Profit. Jelikalite creates medical equipment for kids with autism spectrum …

JelikaLite

Web6 gen 2024 · January 6, 2024. NEW YORK– ( BUSINESS WIRE )–JelikaLite Corp, a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) has granted the Breakthrough Device Designation to its Cognilum System for the reduction of symptoms of moderate to severe autism spectrum disorder in pediatric … WebJelikalite has raised a total of $408.7K in funding over 3 rounds. Their latest funding was raised on Jan 23, 2024 from a Undisclosed round. Jelikalite is funded by 2 investors. … carissa m. knapp https://mmservices-consulting.com

Jelikalite - Funding, Financials, Valuation & Investors - CrunchBase

Web19 dic 2024 · Transcranial Photobiomodulation (tPBM) May Reduce Symptoms of Autism, as measured by Behavioral Change and EEG - a presentation by Eugenia Steingold, PhD, a ... Web4 feb 2024 · JelikaLite Corp introduced in the present day optimistic outcomes from a examine funded by the NSF SBIR Section I grant. This examine demonstrated that tPBM is a doubtlessly efficient remedy modality for enhancing signs of autism in youngsters. Open Label Research had 25 members. Web16 mar 2024 · JelikaLite’s Cognilum™ device is being developed to deliver treatment through transcranial photobiomodulation; the science uses infrared light, delivered through LEDs, ... carissa marie virkus

Eugenia Steingold - Co-Founder - JelikaLite LinkedIn

Category:JelikaLite’s autism reduction device gets FDA breakthrough status

Tags:Jelikalite

Jelikalite

JelikaLite obtains FDA breakthrough device designation for …

WebJelikaLite is developing an innovative solution to permanently reduce a child's autism symptoms. Discover Precision Autism Through Light! WebThe two neurology device companies will join forces in a clinical trial seeking to reduce the symptoms of autism in children. NEW YORK, March 16, 2024 (GLOBE NEWSWIRE) -- via InvestorWire --Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, announces a collaboration with JelikaLite, a company …

Jelikalite

Did you know?

WebJaspillite. Jaspillite, or jaspilite also itabirite, is a chemical rock formed similar to chert, but is generally quite iron rich. It is also known as jasper taconite. Jaspillite is typically a … Web• Joined JelikaLite Corp in the advisory role, transitioned to the Chief Operating Officer role in October. Assist in fund raising, run part of the ongoing clinical trial, help with strategy …

WebJelikaLite Dec 2024 - Present 2 years 5 months. New York, New York, United States VP Advanced Research DJO Global Dec 2024 - Apr 2024 … WebTranscranial photobiomodulation (TPBM) is emerging as a promising treatment modality for Autism Spectrum Disorder. JelikaLite is conducting an open label stu...

Web13 gen 2024 · JelikaLite is working to expand the range of treatment options for young children diagnosed with ASD. FDA granted breakthrough device designation to the … WebGet Luis De Taboada's email address (l*****@litecure.com) and phone number (760889....) at RocketReach. Get 5 free searches.

Web23 dic 2024 · The latest announcements from JelikaLite, a medical technology company with focus on pediatric neurological health using non-invasive novel therapies. February …

Web6 gen 2024 · JelikaLite has been founded and run by a multidisciplinary team, with experts in autism clinical therapy, transcranial photobiomodulation, commercialization of medical … carissa lyrics sun kil moonWebJelikaLite 376 followers on LinkedIn. Developing an intelligent medical device for children on the autism spectrum Autism is a serious developmental disease that lasts a lifetime. … carissa lynnWebSkilled people manager and mentor. Katya is a co-founder and CEO of JelikaLite, a biotech company developing individualized solutions to children with autism and other … carissa mcgaskeyWeb6 gen 2024 · NEW YORK--(BUSINESS WIRE)--JelikaLite Corp, a medical technology company, announced today that the U.S. Food and Drug Administration (FDA) has granted the Breakthrough Device Designation to its ... carissa ninnemanWeb7 gen 2024 · JelikaLite has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its wearable medical device called Cognilum system to reduce autism symptoms. The Cognilum system is designed to lessen symptoms of moderate to severe autism spectrum disorder in paediatric patients aged between two … carissa mine wyomingWebJelikaLite 341 follower su LinkedIn. Developing an intelligent medical device for children on the autism spectrum Autism is a serious developmental disease that lasts a lifetime. The rates of autism continue to rise, the cause of the disease remains unknown and there is no cure. We believe that children on the autism spectrum can lead fulfilling and productive … carissa makeupWebClinical: In October 2024, JelikaLite finished a pivotal double-blind, placebo controlled clinical trial, using JelikaLite's proprietary prototype. The difference between the ‘active group’ and the ‘placebo group’ was … lely juno